Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
28 Mar 2023
Historique:
medline: 31 3 2023
pubmed: 26 12 2022
entrez: 25 12 2022
Statut: ppublish

Résumé

Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis remains unexplored in Japan. This study aimed to investigate the long-term survival and prognostic factors of radioiodine therapy (RIT) in a University Hospital setting. This retrospective study included 62 patients with lung metastases from DTC who received RIT between March 2005 and December 2016. According to the

Identifiants

pubmed: 36567077
doi: 10.1507/endocrj.EJ22-0463
doi:

Substances chimiques

Thyroglobulin 9010-34-8
Iodine Radioisotopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

315-322

Auteurs

Norihito Akatani (N)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Hiroshi Wakabayashi (H)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Daiki Kayano (D)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Anri Inaki (A)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Aki Takata (A)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Tomo Hiromasa (T)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Takafumi Yamase (T)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Yuji Kunita (Y)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Satoru Watanabe (S)

Department of Functional Imaging and Artificial Intelligence, Kanazawa University, Kanazawa 920-8641, Japan.

Hiroshi Mori (H)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Shintaro Saito (S)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Kenichi Nakajima (K)

Department of Functional Imaging and Artificial Intelligence, Kanazawa University, Kanazawa 920-8641, Japan.

Seigo Kinuya (S)

Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa 920-8641, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH